BTVPUR AlSap 2-4

RSS

inactivated adjuvanted vaccine against bluetongue virus serotype 2 and 4 infections

Withdrawn
This medicine is now withdrawn from use in the European Union.

Overview

The marketing authorisation for this product has been withdrawn due to the application of the sunset clause.

This EPAR was last updated on 13/11/2018

Authorisation details

Product details
Name
BTVPUR AlSap 2-4
Agency product number
EMEA/V/C/000139
Active substance
  • bluetongue-virus serotype-2 antigen
  • bluetongue-virus serotype-4 antigen
International non-proprietary name (INN) or common name
inactivated adjuvanted vaccine against bluetongue virus serotype 2 and 4 infections
Species
Sheep
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI04AA02
Publication details
Marketing-authorisation holder
Mérial
Revision
4
Date of issue of marketing authorisation valid throughout the European Union
04/11/2010
Contact address

29 avenue Tony Garnier
69007 Lyon
France

Product information

01/06/2018 BTVPUR AlSap 2-4 - EMEA/V/C/000139 - R/0006

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Immunologicals for ovidae sheep
  • inactivated viral vaccines bluetongue virus

Therapeutic indication

Active immunisation of sheep to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 2 and 4.

Assessment history

News

How useful was this page?

Add your rating
Average
1 rating